Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Low-Risk Prostate Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT01581749
What this trial is testing

Evaluation of Truebeam for Low-Intermediate Risk Prostate Cancer

Who this might be right for
Prostate Neoplasms
Albert DeNittis 50
Not applicableUnknownNCT03225235
What this trial is testing

Prospective Evaluation of Hypofractionated Stereotactic RT Using CyberKnife for Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
The Greater Poland Cancer Centre 600
Testing effectiveness (Phase 2)Study completedNCT00283829
What this trial is testing

Immunotherapy After Chemotherapy for Patients With Hormone Refractory Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
University of Washington 30
Not applicableNot Yet RecruitingNCT07132658
What this trial is testing

MRI-guided Ultrahypofractionated SBRT Prostate Program

Who this might be right for
Prostate Cancer
Clinica Universidad de Navarra, Universidad de Navarra 40
Not applicableStudy completedNCT01368055
What this trial is testing

Hypofractionated Proton Radiation Therapy for Low and Intermediate Risk Prostate Cancer

Who this might be right for
Prostate Cancer
University of Florida 361
Testing effectiveness (Phase 2)WithdrawnNCT06060587
What this trial is testing

Randomized Phase II Study of ADT + Abiraterone vs ADT + Docetaxel + Abiraterone

Who this might be right for
Prostate Cancer
Northwestern University
Testing effectiveness (Phase 2)WithdrawnNCT01409473
What this trial is testing

Stereotactic Body Radiotherapy (SBRT) With Concurrent Boost for Low- and Intermediate-Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Rocky Mountain Cancer Centers
Not applicableActive Not RecruitingNCT01877070
What this trial is testing

Decision Making in Men With Early Stage Prostate Cancer Patients and Partners/Close Allies

Who this might be right for
Low Risk Prostate Cancer
Memorial Sloan Kettering Cancer Center 541
Not applicableActive Not RecruitingNCT05668351
What this trial is testing

Stereotactic Ablative Radiation Therapy for Prostate Cancer

Who this might be right for
Prostate Cancer
Medical University of South Carolina 42
Testing effectiveness (Phase 2)Looking for participantsNCT07410676
What this trial is testing

EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors

Who this might be right for
CancerSarcomaLeukaemia+12 more
Essen Biotech 83
Not applicableActive Not RecruitingNCT02960087
What this trial is testing

Phase II High Dose Brachytherapy and Low Dose Rate Brachytherapy as Monotherapy in Localized Prostate Cancer

Who this might be right for
Prostate Carcinoma
Canadian Cancer Trials Group 334
Not applicableWithdrawnNCT04399824
What this trial is testing

Focal Radiation Therapy for the Treatment of Low or Intermediate-Risk Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaStage I Prostate Cancer American Joint Committee on Cancer (AJCC) v8Stage II Prostate Cancer AJCC v8+3 more
Jonsson Comprehensive Cancer Center
Large-scale testing (Phase 3)Study completedNCT00494546
What this trial is testing

High Versus Low Dose Supplemental External Radiation With Pd-103 for Prostate Cancer

Who this might be right for
Prostate Cancer
VA Puget Sound Health Care System 568
Not applicableLooking for participantsNCT06200974
What this trial is testing

Multi-omic Approach to Study HDR Brachytherapy for Favorable Risk and Low Tier Intermediate Risk Prostate Cancer

Who this might be right for
Localized Prostate Carcinoma
British Columbia Cancer Agency 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT05546268
What this trial is testing

Study of Oral MRT-2359 in Selected Cancer Patients

Who this might be right for
NSCLCSCLCHigh Grade Neuroendocrine Cancer+5 more
Monte Rosa Therapeutics, Inc 174
Not applicableActive Not RecruitingNCT02623933
What this trial is testing

MRI Assisted Focal Boost With HDR Monotherapy for Prostate Cancer Patients

Who this might be right for
Prostate Cancer
Sunnybrook Health Sciences Centre 60
Testing effectiveness (Phase 2)Looking for participantsNCT07562438
What this trial is testing

Prospective Clinical Trial of 177Lu-P17-088 in the Treatment of Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
First Affiliated Hospital of Fujian Medical University 20
Not applicableUnknownNCT05073653
What this trial is testing

68Ga-GRP PET/CT for Imaging in Low and Intermediate Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Xiangya Hospital of Central South University 80
Testing effectiveness (Phase 2)Looking for participantsNCT07552168
What this trial is testing

INSPIRE: INnovative SABR for Prostate Cancer All IREland

Who this might be right for
Prostate Adenocarcinoma
Cancer Trials Ireland 136
Not applicableStudy completedNCT03196778
What this trial is testing

Low Dose Hemi-body Radiation For Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer
Juravinski Cancer Center 21
Next Page